Kiniksa Pharmaceuticals International, plc
Equities
KNSA
GB00BRXB0C07
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.1 USD | +3.52% |
|
+2.74% | +8.89% |
07-01 | Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf | MT |
07-01 | Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from Russell Small Cap Comp Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.89% | 1.36B | |
+15.58% | 121B | |
+16.60% | 110B | |
+18.14% | 25.98B | |
-24.33% | 19.27B | |
-18.56% | 15.99B | |
-17.95% | 15.66B | |
-48.32% | 14.5B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals International, plc
- Wedbush Raises Kiniksa Pharmaceuticals Price Target to $21 From $20, Maintains Outperform Rating